Cargando…

Systemic Administration of siRNA via cRGD-containing Peptide

Although small interfering RNAs (siRNAs) have been demonstrated to specifically silence their target genes in disease models and clinical trials, in vivo siRNA delivery is still the technical bottleneck that limits their use in therapeutic applications. In this study, a bifunctional peptide named RG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yuanyu, Wang, Xiaoxia, Huang, Weiyan, Cheng, Qiang, Zheng, Shuquan, Guo, Shutao, Cao, Huiqing, Liang, Xing-Jie, Du, Quan, Liang, Zicai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547141/ https://www.ncbi.nlm.nih.gov/pubmed/26300278 http://dx.doi.org/10.1038/srep12458

Ejemplares similares

Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice
por: Liao, Wenjie, et al.
Publicado: (2018)

Enhanced Intercellular Delivery of cRGD–siRNA Conjugates by an Additional Oligospermine Modification
por: Nakamoto, Kosuke, et al.
Publicado: (2018)

PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells
por: Li, Tianjiao, et al.
Publicado: (2019)

cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy
por: Yang, Shuang, et al.
Publicado: (2021)

Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA
por: Liu, Xiaoxia, et al.
Publicado: (2014)

Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway
por: Cen, Bohong, et al.
Publicado: (2018)

Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou, Zhaoxiu, et al.
Publicado: (2017)

Feasibility of cRGD conjugation at 5′-antisense strand of siRNA by phosphodiester linkage extension
por: Zhou, Xinyang, et al.
Publicado: (2021)

Pharmacokinetic Behaviors of Intravenously Administered siRNA in Glandular Tissues
por: Huang, Yuanyu, et al.
Publicado: (2016)

The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy
por: Du, Lili, et al.
Publicado: (2017)

A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo
por: He, Shuai, et al.
Publicado: (2017)

Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells
por: Nai, Jingxue, et al.
Publicado: (2021)

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B
por: Huang, Yuanyu, et al.
Publicado: (2022)

cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism
por: Liang, Chunting, et al.
Publicado: (2022)

Site-Specific Modification Using the 2′-Methoxyethyl Group Improves the Specificity and Activity of siRNAs
por: Song, Xinyun, et al.
Publicado: (2017)

Interface Immobilization Chemistry of cRGD-based Peptides Regulates Integrin Mediated Cell Adhesion
por: Pallarola, Diego, et al.
Publicado: (2014)

Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic Payload
por: Perrins, Richard D., et al.
Publicado: (2022)

Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy
por: Wiessler, Manfred, et al.
Publicado: (2011)

Iodine-125-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent
por: Su, Ning, et al.
Publicado: (2015)

Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
por: Dicheva, Bilyana M., et al.
Publicado: (2015)

Alendronate/cRGD-Decorated Ultrafine Hyaluronate Dot Targeting Bone Metastasis
por: Lee, Eunsol, et al.
Publicado: (2020)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
por: Yu, Xiaolin, et al.
Publicado: (2021)

Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line
por: Yu, Xinzhe, et al.
Publicado: (2016)

Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice
por: Hedhli, Jamila, et al.
Publicado: (2018)

Inter-molecular β-sheet structure facilitates lung-targeting siRNA delivery
por: Zhou, Jihan, et al.
Publicado: (2016)

Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020)

siRNA Has Greatly Elevated Mismatch Tolerance at 3′-UTR Sites
por: Wei, Na, et al.
Publicado: (2012)

Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET Imaging
por: Xiao, Yuling, et al.
Publicado: (2012)

Endothelial Cell Targeting by cRGD-Functionalized Polymeric Nanoparticles under Static and Flow Conditions
por: Martínez-Jothar, Lucía, et al.
Publicado: (2020)

Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells
por: Zhou, Ru, et al.
Publicado: (2022)

Scanning Tunneling Microscopy Study of Lipoic Acid, Mannose, and cRGD@AuNPs Conjugates
por: Rodríguez-Galván, Andrés, et al.
Publicado: (2023)

Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets
por: Zhang, Wei, et al.
Publicado: (2022)

Analysis of siRNA specificity on targets with double-nucleotide mismatches
por: Dahlgren, Cecilia, et al.
Publicado: (2008)

Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide
por: Jin, Zhao-Hui, et al.
Publicado: (2022)

Vector-based siRNA delivery strategies for high-throughput screening of novel target genes
por: Chen, Meihong, et al.
Publicado: (2005)

Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
por: Zhang, Jing, et al.
Publicado: (2018)

Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound
por: Li, Zhaojun, et al.
Publicado: (2017)

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
por: Zheng, Shuquan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1va5c9f2l0pqbset01kmedsbla